Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1996 1
2007 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for subsalicylate de bismuto
Your search for subsalicilato-de-bismuto retrieved no results
[Addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection: efficiency and adverse events].
Hinostroza Morales D, Díaz Ferrer J. Hinostroza Morales D, et al. Rev Gastroenterol Peru. 2014 Oct-Dec;34(4):315-20. Rev Gastroenterol Peru. 2014. PMID: 25594755 Clinical Trial. Spanish.
OBJECTIVES: To establish the efficiency and adverse effects of the addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection. ...The study population consisted of 54 patients with Helicobacter pylori infection: 29 were allocat …
OBJECTIVES: To establish the efficiency and adverse effects of the addition of bismuth subsalicylate to triple eradication the …
[The high fermentative capacity of colonic bacteria in the origin of flatulence and its sensibility to bismuth subsalicylate].
León-Barúa R, Alvarez De Roig M, Roig-Arosemena J, Berendson-Seminario R, Torres-Zevallos H. León-Barúa R, et al. Rev Gastroenterol Peru. 2007 Jan-Mar;27(1):21-4. Rev Gastroenterol Peru. 2007. PMID: 17431432 Spanish.
Using a previously described technique, "in vitro" determinations were carried out for faecal fermentation (FF): basal faecal fermentation (BFF), i.e, only with faeces, with faeces and lactulose (LFF) and with faeces, lactulose and bismuth subsalicylate (BiLFF) in 34 patie …
Using a previously described technique, "in vitro" determinations were carried out for faecal fermentation (FF): basal faecal fermentation ( …
[Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
Ramirez Mayans JA, Zamora Davila E, Cervantes Bustamante R, Mata Rivera N, Oyervides Garcia I, Cuevas S, Zarate Mondragón FE. Ramirez Mayans JA, et al. Acta Gastroenterol Latinoam. 1996;26(5):281-3. Acta Gastroenterol Latinoam. 1996. PMID: 9363265 Clinical Trial. Spanish.
OBJECTIVE: Elimination of Helicobacter pylori with Chlaritromicin, Bismuth subsalicylate and Ranitidine; and improvement of recurrent abdominal pain. ...METHOD: 22 children with recurrent abdominal pain associated to gastritis and histologic identification of Helicobacter …
OBJECTIVE: Elimination of Helicobacter pylori with Chlaritromicin, Bismuth subsalicylate and Ranitidine; and improvement of recurrent …
[In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
León-Barúa R, Tello-Casanova R. León-Barúa R, et al. Acta Gastroenterol Latinoam. 1985;15(3):157-64. Acta Gastroenterol Latinoam. 1985. PMID: 3836544 Spanish.
An investigation was done on the action in vitro of two pharmaceutical preparations containing Bi, De Nol and Pepto Bismol, on the fermentative capacity of intestinal bacteria. ...In 11 of the samples, FF was measured without and with addition of De Nol; and in the …
An investigation was done on the action in vitro of two pharmaceutical preparations containing Bi, De Nol and Pepto Bismol, on the fe …